Compensatory upregulation of the adenosine system following phenylephrine-induced hypertrophy in cultured rat ventricular myocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 2, 2010, Pages

  Pang, Theresa ^a   Gan, Xiaohong Tracey ^a   Freeman, David J ^a   Cook, Michael A ^a   Karmazyn, Morris ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Adenosine; Adenosine deaminase; Adenosine receptors; Hypertrophy; Nucleoside transport

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE DEAMINASE; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; ATRIAL NATRIURETIC FACTOR; NUCLEOSIDE TRANSPORTER; NUCLEOSIDE TRANSPORTER 1; NUCLEOSIDE TRANSPORTER 2; PHENYLEPHRINE; PRAZOSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; HEART VENTRICLE HYPERTROPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NEWBORN; NONHUMAN; NUCLEOSIDE TRANSPORT; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; WESTERN BLOTTING;

ADENOSINE; ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HEART VENTRICLES; MYOCYTES, CARDIAC; NUCLEOSIDE TRANSPORT PROTEINS; PHENYLEPHRINE; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; UP-REGULATION;

EID: 74949123730     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00417.2009     Document Type: Article

References (27)

1. Arosio B, Perlini S, Calabresi C, Tozzi R, Palladini G, Ferrari AU, Vergani C, Annoni G. Adenosine A1 and A2A receptor cross-talk during ageing in the rat myocardium. Exp Gerontol 38: 855-861, 2003.
2. Ashton KJ, Nilsson U, Willems L, Holmgren K, Headrick JP. Effects of aging and ischemia on adenosine receptor transcription in mouse myocardium. Biochem Biophys Res Commun 312: 367-372, 2003.
3. Chaudary N, Naydenova Z, Shuralyova I, Coe IR. Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1. Cardiovasc Res 61: 780-788, 2004.
4. Deussen A. Metabolic flux rates of adenosine in the heart. Naunyn Schmiedebergs Arch Pharmacol 362: 351-363, 2000.
5. Deussen A, Stappert M, Schafer S, Kelm M. Quantification of extra-cellular and intracellular adenosine production: understanding the transmembranous concentration gradient. Circulation 99: 2041-2047, 1999.
6. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65: 45-79, 2003.
7. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation 109: 1580-1589, 2004.
8. Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, Hori M. Plasma adenosine levels increase in patients with chronic heart failure. Circulation 95: 1363-1365, 1997.
9. Gan XT, Rajapurohitam V, Haist JV, Chidiac P, Cook MA, Karmazyn M. Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes. J Pharmacol Exp Ther 312: 27-34, 2005.
10. Grden M, Podgorska M, Szutowicz A, Pawelczyk T. Altered expression of adenosine receptors in heart of diabetic rat. J Physiol Pharmacol 56: 587-597, 2005.
11. Headrick JP, Hack B, Ashton KJ. Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol Heart Circ Physiol 285: H1797-H1818, 2003.
12. ATP channel. J Pharmacol Exp Ther 294: 770-777, 2000.
13. Jenner TL, Mellick AS, Harrison GJ, Griffiths LR, Rose'Meyer RB. Age-related changes in cardiac adenosine receptor expression. Mech Ageing Dev 125: 211-217, 2004.
14. 1-Adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation 91: 2226-2234, 1995.
15. Kitakaze M, Minamino T, Node K, Koretsune Y, Komamura K, Funaya H, Kuzuya T, Hori M. Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure. Cardiovasc Drugs Ther 12: 307-309, 1998.
16. 1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Circ Res 93: 759-766, 2003.
17. 3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle. Circulation 118: 1713-1721, 2008.
18. Lu YM, Han F, Shioda N, Moriguchi S, Shirasaki Y, Qin ZH, Fukunaga K. Phenylephrine-induced cardiomyocyte injury is triggered by superoxide generation through uncoupled endothelial nitric-oxide synthase and ameliorated by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl] ethyl]-5,6-dimethoxyindazole (DY-9836), a novel calmodulin antagonist. Mol Pharmacol 75: 101-112, 2009.
19. Peart JN, Headrick JP. Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol Ther 114: 208-221, 2007.
20. Rose JB, Coe IR. Physiology of nucleoside transporters: back to the future. Physiology (Bethesda) 23: 41-48, 2008.
21. Sato T, Obata T, Yamanaka Y, Arita M. Stimulation of alpha 1-adrenoceptors and protein kinase C-mediated activation of ecto-5′- nucleotidase in rat hearts in vivo. J Physiol 503: 119-127, 1997.
22. 1-adrenergic receptors in cardiac pathophysiology. Am Heart J 152: 842-850, 2006.
23. Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79: 2-10, 1997.
24. Thomas S, Rich M. Epidemiology, pathophysiology, and prognosis of heart failure in the elderly. Clin Geriatr Med 23: 1-10, 2007.
25. 2+ current in cat atrial myocytes. J Physiol 567: 143-157, 2005.
26. Xu X, Fassett J, Hu X, Zhu G, Lu Z, Li Y, Schnermann J, Bache RJ, Chen Y. Ecto-5′-nucleotidase deficiency exacerbates pressure-overload- induced left ventricular hypertrophy and dysfunction. Hypertension 51: 1557-1564, 2008.
27. Zoref-Shani E, Kessler-Icekson G, Sperling O. Pathways of adenine nucleotide catabolism in primary rat cardiomyocyte cultures. J Mol Cell Cardiol 20: 23-33, 1988.